137
Views
18
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLEClinical Translational Therapeutics

Expression and Mutation Analysis of Her2 in Head and Neck Squamous Cell Carcinoma

, , , , , , , , , & show all
Pages 495-500 | Published online: 16 Dec 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

BR Koltz, DG Hicks & CL Whitney-Miller. (2012) HER2 testing in gastric and esophageal adenocarcinoma: new diagnostic challenges arising from new therapeutic options. Biotechnic & Histochemistry 87:1, pages 40-45.
Read now

Articles from other publishers (17)

Camilla Palumbo, Monica Benvenuto, Chiara Focaccetti, Loredana Albonici, Loredana Cifaldi, Alessandra Rufini, Daniela Nardozi, Valentina Angiolini, Arianna Bei, Laura Masuelli & Roberto Bei. (2023) Recent findings on the impact of ErbB receptors status on prognosis and therapy of head and neck squamous cell carcinoma. Frontiers in Medicine 10.
Crossref
Giovanni Almadori, Antonella Coli, Eugenio De Corso, Dario Antonio Mele, Stefano Settimi, Giovanni Di Cintio, Francesca Brigato, Domenico Scannone, Thomas E. Carey, Gaetano Paludetti, Libero Lauriola & Franco Oreste Ranelletti. (2021) Nuclear HER3 expression improves the prognostic stratification of patients with HER1 positive advanced laryngeal squamous cell carcinoma. Journal of Translational Medicine 19:1.
Crossref
Emilie A. K. Warren, Joshua Anil, Patricia D. Castro, Jan Kemnade, Masataka Suzuki, Meenakshi Hegde, John Hicks, Wendong Yu, Vlad Sandulache & Andrew G. Sikora. (2021) Human epidermal growth factor receptor 2 expression in head and neck squamous cell carcinoma: Variation within and across primary tumor sites, and implications for antigen‐specific immunotherapy. Head & Neck 43:7, pages 1983-1994.
Crossref
Jessica Yesensky, Alexandra Kyrillos, Kristine Kuchta, Katharine Yao, Chi‐Hsiung Wang & Mihir K. Bhayani. (2017) Risk of Development of Second Primary Head and Neck Cancer following an Index Breast Cancer. Otolaryngology–Head and Neck Surgery 158:2, pages 303-308.
Crossref
Sagun Parakh, Hui K. Gan, Adam C. Parslow, Ingrid J.G. Burvenich, Antony W. Burgess & Andrew M. Scott. (2017) Evolution of anti-HER2 therapies for cancer treatment. Cancer Treatment Reviews 59, pages 1-21.
Crossref
Jun Zhang, Nabil F. Saba, Georgia (Zhuo) Chen & Dong M. Shin. (2015) Targeting HER (ERBB) signaling in head and neck cancer: An essential update. Molecular Aspects of Medicine 45, pages 74-86.
Crossref
Netanya I. Pollock & Jennifer R. Grandis. (2015) HER2 as a Therapeutic Target in Head and Neck Squamous Cell Carcinoma. Clinical Cancer Research 21:3, pages 526-533.
Crossref
Vinicius Ernani & Nabil F. Saba. (2015) Oral Cavity Cancer: Risk Factors, Pathology, and Management. Oncology 89:4, pages 187-195.
Crossref
Huei Ng, Aiping Lu, Ge Lin, Ling Qin & Zhijun Yang. (2014) The Potential of Liposomes with Carbonic Anhydrase IX to Deliver Anticancer Ingredients to Cancer Cells in Vivo. International Journal of Molecular Sciences 16:1, pages 230-255.
Crossref
Edward L Nelson. (2014) HER2/neu: an increasingly important therapeutic target. Part 2: Distribution of HER2/neu overexpression and gene amplification by organ, tumor site and histology. Clinical Investigation 4:8, pages 705-728.
Crossref
Yoko Takahashi, Diana Bell, Garima Agarwal, Dianna Roberts, Tong-Xin Xie, Adel El-Naggar, Jeffrey N. Myers & Ehab Y. Hanna. (2014) Comprehensive assessment of prognostic markers for sinonasal squamous cell carcinoma. Head & Neck 36:8, pages 1094-1102.
Crossref
Henning Hanken, Robert Gaudin, Alexander Gröbe, Meike Fraederich, Wolfgang Eichhorn, Ralf Smeets, Ronald Simon, Guido Sauter, Katharina Grupp, Jacob R. Izbicki, Susanne Sehner, Max Heiland & Marco Blessmann. (2014) Her2 expression and gene amplification is rarely detectable in patients with oral squamous cell carcinomas. Journal of Oral Pathology & Medicine 43:4, pages 304-308.
Crossref
Fernando López, José Luis Llorente, María Costales, Cristina García-Inclán, Jhudit Pérez-Escuredo, César Álvarez-Marcos, Mario Hermsen & Carlos Suárez. (2013) Caracterización molecular de los carcinomas nasosinusales y sus implicaciones clínicas. Acta Otorrinolaringológica Española 64:4, pages 289-296.
Crossref
Fernando López, José Luis Llorente, María Costales, Cristina García-Inclán, Jhudit Pérez-Escuredo, César Álvarez-Marcos, Mario Hermsen & Carlos Suárez. (2013) Molecular Characterisation of Sinonasal Carcinomas and Their Clinical Implications. Acta Otorrinolaringologica (English Edition) 64:4, pages 289-296.
Crossref
Anna M. Eliassen, Samantha J. Hauff, Alice L. Tang, Dafydd H. Thomas, Jonathan B. McHugh, Heather M. Walline, Jay Stoerker, Jessica H. Maxwell, Francis P. Worden, Avraham Eisbruch, Michael J. Czerwinski, Silvana M. Papagerakis, Douglas B. Chepeha, Carol R. Bradford, David A. Hanauer, Thomas E. Carey & Mark E. Prince. (2013) Head and neck squamous cell carcinoma in pregnant women. Head & Neck 35:3, pages 335-342.
Crossref
Fernando López, José Luis Llorente, Carlos Martín Oviedo, Blanca Vivanco, César Álvarez Marcos, Cristina García‐Inclán, Bartolomé Scola & Mario A. Hermsen. (2011) Gene amplification and protein overexpression of EGFR and ERBB2 in sinonasal squamous cell carcinoma. Cancer 118:7, pages 1818-1826.
Crossref
. (2011) Current World Literature. Current Opinion in Oncology 23:3, pages 303-310.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.